Literature DB >> 18809579

PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation.

Yutaka Shima1, Takito Shima, Tomoki Chiba, Tatsuro Irimura, Pier Paolo Pandolfi, Issay Kitabayashi.   

Abstract

PML, a nuclear protein, interacts with several transcription factors and their coactivators, such as HIPK2 and p300, resulting in the activation of transcription. Although PML is thought to achieve transcription activation by stabilizing the transcription factor complex, little is known about the underlying molecular mechanism. To clarify the role of PML in transcription regulation, we purified the PML complex and identified Fbxo3 (Fbx3), Skp1, and Cullin1 as novel components of this complex. Fbx3 formed SCF(Fbx3) ubiquitin ligase and promoted the degradation of HIPK2 and p300 by the ubiquitin-proteasome pathway. PML inhibited this degradation through a mechanism that unexpectedly did not involve inhibition of the ubiquitination of HIPK2. PML, Fbx3, and HIPK2 synergistically activated p53-induced transcription. Our findings suggest that PML stabilizes the transcription factor complex by protecting HIPK2 and p300 from SCF(Fbx3)-induced degradation until transcription is completed. In contrast, the leukemia-associated fusion PML-RARalpha induced the degradation of HIPK2. We discuss the roles of PML and PML-retinoic acid receptor alpha, as well as those of HIPK2 and p300 ubiquitination, in transcriptional regulation and leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809579      PMCID: PMC2593379          DOI: 10.1128/MCB.00897-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation.

Authors:  Hitoshi Yoshida; Hitoshi Ichikawa; Yusuke Tagata; Takuo Katsumoto; Kazunori Ohnishi; Yukihiro Akao; Tomoki Naoe; Pier Paolo Pandolfi; Issay Kitabayashi
Journal:  Mol Cell Biol       Date:  2007-06-11       Impact factor: 4.272

2.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.

Authors:  H Miyoshi; K Shimizu; T Kozu; N Maseki; Y Kaneko; M Ohki
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia.

Authors:  A D Goddard; J Borrow; P S Freemont; E Solomon
Journal:  Science       Date:  1991-11-29       Impact factor: 47.728

4.  A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein.

Authors:  J A Dyck; G G Maul; W H Miller; J D Chen; A Kakizuka; R M Evans
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 5.  Chromosomal translocations in human cancer.

Authors:  T H Rabbitts
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

6.  Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors.

Authors:  M O Imhof; D P McDonnell
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

7.  PML regulates p53 stability by sequestering Mdm2 to the nucleolus.

Authors:  Rosa Bernardi; Pier Paolo Scaglioni; Stephan Bergmann; Henning F Horn; Karen H Vousden; Pier Paolo Pandolfi
Journal:  Nat Cell Biol       Date:  2004-06-13       Impact factor: 28.824

8.  The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR.

Authors:  H de Thé; C Lavau; A Marchio; C Chomienne; L Degos; A Dejean
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

9.  Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML.

Authors:  A Kakizuka; W H Miller; K Umesono; R P Warrell; S R Frankel; V V Murty; E Dmitrovsky; R M Evans
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

10.  Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription.

Authors:  X-L Li; Y Arai; H Harada; Y Shima; H Yoshida; S Rokudai; Y Aikawa; A Kimura; I Kitabayashi
Journal:  Oncogene       Date:  2007-05-28       Impact factor: 9.867

View more
  33 in total

1.  CAR Suppresses Hepatic Gluconeogenesis by Facilitating the Ubiquitination and Degradation of PGC1α.

Authors:  Jie Gao; Jiong Yan; Meishu Xu; Songrong Ren; Wen Xie
Journal:  Mol Endocrinol       Date:  2015-09-25

2.  An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response.

Authors:  Marco A Calzado; Laureano de la Vega; Andreas Möller; David D L Bowtell; M Lienhard Schmitz
Journal:  Nat Cell Biol       Date:  2008-11-30       Impact factor: 28.824

Review 3.  Regulation of histone modifying enzymes by the ubiquitin-proteasome system.

Authors:  Chunbin Zou; Rama K Mallampalli
Journal:  Biochim Biophys Acta       Date:  2014-01-03

4.  Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH.

Authors:  Markus Kainulainen; Matthias Habjan; Philipp Hubel; Laura Busch; Simone Lau; Jacques Colinge; Giulio Superti-Furga; Andreas Pichlmair; Friedemann Weber
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

5.  Cellular senescence and protein degradation: breaking down cancer.

Authors:  Xavier Deschênes-Simard; Frédéric Lessard; Marie-France Gaumont-Leclerc; Nabeel Bardeesy; Gerardo Ferbeyre
Journal:  Cell Cycle       Date:  2014-05-27       Impact factor: 4.534

6.  The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.

Authors:  Nina Reuven; Julia Adler; Ziv Porat; Tilman Polonio-Vallon; Thomas G Hofmann; Yosef Shaul
Journal:  J Biol Chem       Date:  2015-05-05       Impact factor: 5.157

Review 7.  Posttranslational modifications regulate HIPK2, a driver of proliferative diseases.

Authors:  Vera V Saul; M Lienhard Schmitz
Journal:  J Mol Med (Berl)       Date:  2013-04-25       Impact factor: 4.599

8.  FBXO3 Protein Promotes Ubiquitylation and Transcriptional Activity of AIRE (Autoimmune Regulator).

Authors:  Wei Shao; Kristina Zumer; Koh Fujinaga; B Matija Peterlin
Journal:  J Biol Chem       Date:  2016-06-30       Impact factor: 5.157

Review 9.  New insights on the function of SCF ubiquitin E3 ligases in the lung.

Authors:  Nathaniel M Weathington; Rama K Mallampalli
Journal:  Cell Signal       Date:  2013-05-14       Impact factor: 4.315

Review 10.  A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics.

Authors:  Ellen Van Damme; Kris Laukens; Thanh Hai Dang; Xaveer Van Ostade
Journal:  Int J Biol Sci       Date:  2010-01-12       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.